Health ❯ Healthcare ❯ Patient Care ❯ Treatment Options

Innovative Therapies

EU Advisers Back Susvimo Implant as New Option for Wet Age‑Related Macular Degeneration

A European Commission decision and publication of official prescribing information are required before the refillable ranibizumab implant can be used by trained vitreoretinal surgeons.

4 ARTICLES

3mo ago

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

3 ARTICLES

8mo ago

NICE Endorses Dupilumab as First Targeted Biologic for Uncontrolled Eosinophilic COPD

3 ARTICLES

last yr.

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

3 ARTICLES

last yr.

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free